Zenas BioPharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Zenas BioPharma, Inc. (ZBIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 226.32 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-13
- Zenas BioPharma, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 193.19K shares, a 29.46% decline year-over-year.
- Zenas BioPharma, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 33.13K shares, a 71.23% decline year-over-year.
- Zenas BioPharma, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 135.97K shares.
- Zenas BioPharma, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-06-30 was 273.89K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month |
|---|---|---|---|
| 2026-06-30 | 193.19K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 226.32K shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 33.13K shares 10-Q · filed 2026-05-13 | ||
| 2025-09-30 | 135.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 409.86K shares derived: sum of 2 quarters · filed 2025-11-12 | 525.01K shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 273.89K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 389.04K shares 10-Q · filed 2025-08-12 | |
| 2025-03-31 | 115.15K shares 10-Q · filed 2025-05-15 |